Bynfezia Pen

Indicated For

acromegaly, carcinoid syndrome

About This Medication

# Bynfezia Pen Patient Guide: How to Get Bynfezia Pen at Low or No Cost Bynfezia Pen (octreotide acetate) is a prescription medication used to treat serious conditions like acromegaly and symptoms of certain cancers, but specific manufacturer patient assistance programs are not clearly detailed in available resources. This guide provides patient-friendly information on potential cost-saving options, including copay assistance, insurance navigation, and general strategies based on current data.[1][4] ## About Bynfezia Pen **Bynfezia Pen** is a prefilled, single-patient-use pen containing octreotide acetate injection (2,500 mcg/mL, total 7,000 mcg/2.8 mL). It is administered subcutaneously to reduce growth hormone and IGF-1 levels in acromegaly patients who do not respond adequately to surgery, radiation, or bromocriptine. It also helps control flushing and watery diarrhea from carcinoid tumors or VIPomas.[1][4][6] Octreotide mimics somatostatin, a natural hormone that inhibits hormone secretions. Unlike long-acting depot forms like Sandostatin LAR, Bynfezia Pen is for daily or frequent short-acting use, often up to 750-1,500 mcg per day in divided doses.[3][6][8] There are no generic alternatives available, making it costly without assistance—potentially thousands per treatment cycle.[1][7] Common side effects include injection site pain, nausea, diarrhea, and gallstones; monitor progress with your doctor.[4] It's prescribed by endocrinologists or oncologists for adults 18+.[3][8] ## Who Qualifies for Assistance? No specific manufacturer-sponsored patient assistance program (PAP) for Bynfezia Pen was identified with details like income thresholds or direct enrollment. However, patients may access help through: - **Copay cards** for commercial insurance (potentially $0 out-of-pocket).[2] - **Specialty pharmacies** like QuickRx, offering free enrollment in copay programs, prior authorizations, and foundation grants.[2] - **Insurance coverage** under Medicare Part D or commercial plans, though prior authorization is often required.[1][3] Eligibility typically requires a valid prescription for FDA-approved uses (acromegaly, carcinoid syndrome), U.S. residency, and meeting insurance or income criteria for PAPs. Medicare patients may need PAPs or low-income subsidies (LIS).[1][2] ## Income Eligibility Breakdown Specific income thresholds for a Bynfezia Pen PAP are unavailable. General PAPs (e.g., via manufacturer or foundations) often use **400-500% of the Federal Poverty Level (FPL)**. Here's a sample table based on common U.S. PAP guidelines (2026 estimates; verify current FPL): | Household Size | 400% FPL (Annual Income) | 500% FPL (Annual Income) | Notes | |----------------|---------------------------|---------------------------|--------| | **Individual** | ~$60,000 | ~$75,000 | Uninsured or underinsured[2] | | **Couple** | ~$81,000 | ~$101,000 | Add ~$21,000 per extra person | | **Family of 3**| ~$102,000 | ~$127,000 | Medicare patients often qualify via LIS | | **Family of 4**| ~$123,000 | ~$153,000 | Foundations may cover gaps[7] | *Notes: Exact criteria vary; contact specialty pharmacies for coordination. No government insurance copay cards.*[2][7] ## Insurance Requirements **Bynfezia Pen is covered by some Medicare and commercial plans**, but prior authorization (PA) is standard.[1][3] Requirements include: - Endocrinologist/oncologist prescription.[3][8] - Age 18+.[3] - Inadequate response to surgery/radiation for acromegaly.[6][9] - Dose limits (e.g., ≤750 mcg/day).[6][8] Medicare: Covered under Part D; use Extra Help/LIS for low-income. Commercial: Copay cards may cap at $0-$50/month.[1][2] Government insurance patients pivot to PAPs.[2] Always try generics first if available, though none for Bynfezia Pen.[1][8] ## Step-by-Step Application Process 1. **Get a Prescription**: Discuss with your endocrinologist/oncologist; confirm FDA indication.[3][6] 2. **Contact Specialty Pharmacy**: Call QuickRx or similar (free support) at their listed number for copay/PAP enrollment, PA help.[2] 3. **Check Insurance**: Verify coverage; submit PA if needed (24-48 hour approvals common).[2][3] 4. **Apply for Copay Assistance**: For commercial insurance, enroll via pharmacy partner (e.g., Inside RX/Sun Pharmaceutical discounts).[1][2] 5. **PAP for Uninsured/Medicare**: Search PAN Foundation or RxAssist.org; provide income proof.[7] 6. **Submit Documents**: Proof of income, insurance denial (if applicable), ID.[2] 7. **Home Delivery**: Temperature-controlled shipping arranged.[2] Call 1-833-346-2277 (similar programs) for guidance.[5][7] ## Timeline and Delivery - **PA Approval**: 24-48 hours for commercial; 1-6 months initial for Medicaid/commercial.[2][6] - **Copay/PAP Processing**: Days to weeks.[2] - **Delivery**: Home via specialty pharmacy, refrigerated.[2][4] Reauthorization yearly with lab proof (GH/IGF-1 control).[3][6] ## Alternatives if Denied - **Switch to Sandostatin (generic octreotide)**: Preferred in some policies; similar efficacy.[8][9] - **Mycapssa (oral octreotide)**: Copay program available (Chiesi Total Care, $0 copay).[5][7] - **Lanreotide**: Alternative somatostatin analog.[7] - **GoodRx/Inside RX Discounts**: Cash-pay reductions.[1] - **Foundation Grants**: Acromegaly Community resources.[7] - **Appeal Denial**: Provide more clinical data.[3] ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Assistance availability changes; verify with providers. Costs can exceed $3,000/shot insured.[1][7] Consult your doctor/pharmacist. Data current as of available sources; no direct Bynfezia PAP confirmed.

Program information last verified: March 30, 2026